Viewing Study NCT03272568

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:28 PM
Ignite Modification Date: 2026-02-20 @ 4:46 PM
Study NCT ID: NCT03272568
Status: COMPLETED
Last Update Posted: 2020-05-18
First Post: 2017-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers
Sponsor: Emory University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia View
None Menstrual Flow Excessive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Extended Life Plasma Derived Factor Products View
None Female hemophilia A and B carriers View
None Menorrhagia View